Understanding how GLP-1 (semaglutide) medications work can be a game-changer for women navigating peri/menopause and beyond, especially when it comes to managing weight and hunger. 

These medications are designed to mimic natural hormones in your gut that regulate hunger and digestion. As we age and experience hormonal fluctuations, especially during the menopause transition, controlling appetite becomes a bigger challenge. GLP-1s step in by targeting the brain’s hunger signals, helping to create a feeling of fullness and reduce cravings. This can be particularly beneficial for women who find themselves struggling with weight gain, menopause belly, or those who feel like they are constantly battling food cravings during hormonal shifts.

Hunger lives in the brain: how GLP-1s help

Our hunger and satiety signals are regulated by the brain, making it the central control system for our appetites. During menopause, hormonal fluctuations, such as the decline in estrogen, can make these hunger cues less reliable. GLP-1 medications, such as semaglutide and tirzepatide, work by mimicking natural gut hormones that communicate with the brain to signal fullness. This not only helps control appetite but can also improve your body's ability to regulate food intake. The result? A reduction in hunger which can make it easier to stick to a healthier, balanced diet.

Suppressing hunger signals and reducing food cravings

GLP-1s help suppress hunger signals in the brain, which means fewer urges to snack and more consistent control over your eating habits. For women in midlife, these medications can be an effective tool in reducing the constant battle with cravings for sweets, carbs, or unhealthy snacks. 

This can be especially important as many women notice an increase in cravings or difficulty managing portion sizes during perimenopause and post-menopause. By regulating appetite, GLP-1s can support long-term weight management and help prevent emotional eating triggered by hormonal fluctuations.

Aiding weight loss with fewer cravings

As a result of the reduced hunger signals and cravings, GLP-1 medications support weight loss by helping individuals consume fewer calories throughout the day. This becomes even more crucial during menopause when metabolic rates slow down, and weight gain becomes more common. 

GLP-1s can help create a sustainable weight loss strategy by assisting in portion control, making it easier to maintain a calorie deficit without the intense hunger or constant food cravings that can often derail progress. For women navigating this transitional phase, GLP-1s offer a powerful way to manage hunger, support healthy eating patterns, and ultimately achieve weight loss goals.

Why weight loss with Evernow

At Evernow, we specialize in expert care for women 40+ with personalized treatment plans that address the unique challenges of midlife. By combining GLP-1 medications with hormone replacement therapy (HRT) and tailored lifestyle programs, we help women effectively manage weight, reduce cravings, and improve overall health during peri, menopause and beyond. Our comprehensive approach supports not just weight loss but also your overall well-being, with a focus on nutrition, exercise, and lifestyle changes for lasting results.

Incorporating GLP-1 medications into a comprehensive weight loss plan, which includes balanced nutrition and regular exercise, can be a game-changer for women during midlife. By addressing hunger directly at the source, GLP-1s empower women to feel in control of their eating habits, which can make weight loss and maintenance much more manageable during this critical life stage.

‍